pivekimab sunirine-pvzy
pivekimab sunirine-pvzy is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including DECNUPAZ. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- pivekimab sunirine-pvzy
- Brand Names
- DECNUPAZ
- Application Number
- BLA761460
- Sponsor
- AbbVie Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- PIVEKIMAB SUNIRINE
Indications and Usage
1. INDICATIONS AND USAGE DECNUPAZ is indicated for the treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). DECNUPAZ is a CD123-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). ( 1 )